Kim KS, Chan AW, Belley-Côté EP, Drucker AM. Noninferiority Randomized Controlled Trials. J Invest Dermatol. 2022 Jul;142(7):1773-1777. doi: 10.1016/j.jid.2022.04.015. PMID: 35715156.
project details
Noninferiority Randomized Controlled Trials
view our other projects
Building trial capacity in systemic sclerosis: setting the stage for cohort-embedded pragmatic clinical trials
Université de Montréal
8 Sites
ON, QC, AB, BC, MB
Can‑PG: A Canadian Network for Pyoderma Gangrenosum Patients and Outcomes
Women’s College Hospital - University of Toronto
6 Sites
ON, QC, AB, BC, NL
Optimization of a mouse xenograph platform to study BCC progression
Centre de recherche du CHU de Québec – Université Laval
2 Sites
QC
Immune-Mediated Pathways of Aberrant Scarring: Establishing a Canadian Collaborative Platformfor Translational Skin Research to Develop an Atlas of Skin Fibrosis
University of Calgary
3 Sites
AB, QC
Chemoprevention of cutaneous squamous cell carcinoma using topical 5-fluorouracil based therapies in solid organ transplant recipients: multicentre, pragmatic, parallel three group randomized trial
Women’s College Hospital
East-West national Indigenous atopic dermatitis community and research collaborative core seed working group
First Nations University of Canada
4 Sites
SK, QC, MB
Surgical management of hidradenitis suppurativa with deroofing vs wide local excision: a multi-centre retrospective cohort study
University of Toronto, Women’s College Hospital
4 Sites
ON, QC, BC, AL
Canadian Frostbite Collaborative Network Symposium and Research Planning
NOSM University
2 Sites
YK, MB
The Development of a Psychodermatology Risk Assessment Tool: Improving Care for Patients with Atopic Dermatitis and Other Psychodermatologic Conditions
The University of Alberta, Kaye Edmonton Clinic
2 Sites
AL, QC
Development of multicentre Burn Platform adaptive Trials team
The University of Manitoba
8 Sites
WPG, QC, ON, BC, AL
Development of a multi-center research team to explore the potential of anti-mesothelin 1 gene therapies for fibrotic scleroderma
The University of British Columbia
3 Sites
BC, AL, QC
A New Patient-Researcher Partnership for Research on Itch inSystemic Sclerosis
Lady Davis Institute for Medical Research
6 Sites
ON, QC
Setting up the conditions for the biobanking of tissues and cells from hypertrophic scars
Université Laval
2 Sites
MB, QC
Hidradenitis Suppurativa in Diverse Patient Populations: Multicenter Pilot Project to Assess Disease Characteristics and Access to Biologic Therapy
Sunnybrook Research Institute
7 Sites
MB, QC, ON